Traws Pharma (TRAW) Restructuring Costs (2024 - 2026)
Traws Pharma (TRAW) posted quarterly Restructuring Costs of $583000.0 for Q1 2026, down 68.49% year-over-year from $1.8 million in Q1 2025, and down 34.42% quarter-over-quarter from $889000.0 in Q4 2025.
Traws Pharma (TRAW) Restructuring Costs (2024 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Restructuring Costs for 3 consecutive years, with $583000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs fell 68.49% year-over-year to $583000.0; the TTM figure through Mar 2026 stood at $2.5 million (down 45.82% YoY), while the FY2025 annual figure was $2.6 million, down 21.48% from the prior year.
- Restructuring Costs fell to $583000.0 in Q1 2026 per TRAW's latest filing, from $889000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $2.6 million in Q1 2024 and bottomed at $499000.0 in Q3 2025.
- Historically, Restructuring Costs has averaged $1.1 million across 3 years, with a median of $889000.0 in 2025.
- Annual changes were most pronounced in 2025 — Restructuring Costs dropped 8.35% — and 2026, when it slumped 68.49%.
- Traws Pharma's Restructuring Costs stood at $970000.0 in 2024, then fell by 8.35% to $889000.0 in 2025, then sank by 34.42% to $583000.0 in 2026.
- Business Quant data shows TRAW's Restructuring Costs at $583000.0 in Q1 2026, $889000.0 in Q4 2025, and $499000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 583,000.00 |
| Dec 31, 2025 | 889,000.00 |
| Sep 30, 2025 | 499,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 970,000.00 |
| Sep 30, 2024 | 972,000.00 |
| Jun 30, 2024 | 852,000.00 |
| Mar 31, 2024 | 2.58 Mn |